Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The development of type-2 diabetes mellitus (T2DM) and its complications is largely due to the complex interaction between genetic factors and environmental influences, mainly dietary habits and lifestyle, which can either accelerate or slow down disease progression. Recent findings suggest the potential involvement of epigenetic mechanisms as a crucial interface between the effects of genetic predisposition and environmental factors. The common denominator of environmental factors promoting T2DM development and progression is that they trigger an inflammatory response, promoting inflammation-mediated insulin resistance and endothelial dysfunction. Proinflammatory stimuli, including hyperglycemia, oxidative stress, and other inflammatory mediators, can affect epigenetic mechanisms, altering the expression of specific genes in target cells without changes in underlying DNA sequences. DNA methylation and post-translational histone modifications (PTHMs) are the most extensively investigated epigenetic mechanisms. Over the past few years, non-coding RNA, including microRNAs (miRNAs), have also emerged as key players in gene expression modulation. MiRNAs can be actively released or shed by cells in the bloodstream and taken up in active form by receiving cells, acting as efficient systemic communication tools. The miRNAs involved in modulation of inflammatory pathways (inflammamiRs), such as miR-146a, and those highly expressed in endothelial lineages and hematopoietic progenitor cells (angiomiRs), such as miR-126, are the most extensively studied circulating miRNAs in T2DM. However, data on circulating miRNA signatures associated with specific diabetic complications are still lacking. Since immune cells and endothelial cells are primarily involved in the vascular complications of T2DM, their relative contribution to circulating miRNA signatures needs to be elucidated. An integrated approach encompassing different epigenetic mechanisms would have the potential to provide new mechanistic insights into the genesis of diabetes and its severe vascular complications and identify a panel of epigenetic markers with diagnostic/prognostic and therapeutic relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Aging is associated with a chronic systemic inflammatory state, named inflammaging, which greatly contributes to diabetes onset and progression [26, 27].”
BackgroundSelf-citationThe impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592 · cited 1×
“MiRNAs were previously thought to act mainly as negative regulators of gene expression by binding to 3-UTR regions of their target protein-coding mRNAs in a sequencedependent manner [21].”
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 1×
“Proinflammatory cytokines receptors, NOD-like Receptors (NLRs) and Toll-like receptor (TLR) pathways play a significant role in the pathogenesis of inflammaging and inflammationmediated insulin resistance [59–61].”
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“, cytokines, growth factors, metalloproteinases, and other metabolites that contribute to induce and maintain a proinflammatory microenvironment [32].”
BackgroundEl-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115 · cited 1×
“In particular, some epigenetic alterations have been observed in the NF-kB promoter region, leading to increased expression of NF-kB subunit p65, such as: 1) recruitment of the histone methyltransferase Set7 and increased monomethylation of H3K4 (lysine 4 of histone 3) [37, 38]; 2) increased recruitment of the histone…”
BackgroundSalminen, A., Kauppinen, A., & Kaarniranta, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.006 · Cited by 763 · cited 3×
“Histone H3K9 acetylation has been detected in monocytes from diabetic patients as having TNFα overexpression and enhanced activation of cyclo-oxygenase (COX)-2, which have an important role in the induction and maintenance of inflammatory processes [41].”
BackgroundCollino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011803 · Cited by 608
Coppé, J.-P., Rodier, F., Patil, C. K., Freund, A., Desprez, P.-Y., & Campisi, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257071 · Cited by 506
IsomiRs – the overlooked repertoire in the dynamic microRNAome
Neilsen, C. T., Goodall, G. J., & Bracken, C. P. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.005 · Cited by 499 · cited 1×
“More than 2000 human miRNAs have been identified, making them one of the most abundant classes of epigenetic regulatory molecules [20].”
BackgroundHDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428 · cited 1×
“, Argonaute) [62–65].”
Cited by
The integration of inflammaging in age-related diseases
Fulop, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 348
Self-citationPrattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1810327 · Cited by 129
“Epigenetic modifications leading to chronic inflammation have been described in ECs and immune cells of diabetes patients also in the absence of replicative senescence biomarkers [23, 57, 58].”
BackgroundSelf-citationOlivieri, F., Spazzafumo, L., Bonafè, M., Recchioni, R., Prattichizzo, F., Marcheselli, F., Micolucci, L., Mensà, E., Giuliani, A., Santini, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6164 · Cited by 117
Self-citation
Metadata
- Authors
- Prattichizzo, F., Giuliani, A., Ceka, A., Rippo, M. R., Bonfigli, A. R., Testa, R., Procopio, A. D., & Olivieri, F.
- Venue
- Clinical Epigenetics
- Published
- 2015-05-23
- Volume
- 7
- Issue
- 1
- Pages
- 56-56
- ISSN
- 1868-7075 (ISSN-L)
- 1868-7083
- OpenAlex
- W2115103884
- Cited by
- 97
- References
- 23
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. https://app.cochat.ai/papers/10.1186/s13148-015-0090-4
- The paper
- Prattichizzo, F., Giuliani, A., Ceka, A., Rippo, M. R., Bonfigli, A. R., Testa, R., Procopio, A. D., & Olivieri, F. (2015). Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. Clinical Epigenetics. https://doi.org/10.1186/s13148-015-0090-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.